Recent Finacing
Recent Raise
Bluebird bio is a Cambridge- and Paris-based biotech developing lentiviral-vector gene therapies for severe genetic disorders such as beta-thalassemia, sickle cell anemia, and childhood cerebral adrenoleukodystrophy.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
